Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.
An R75W mutation in the gap junction β2 (GJB2) gene causes severe fragmentation of gap junction plaques, connecting adjacent ...
1d
News-Medical.Net on MSNTransforming genetic deafness treatment with base editingCongenital hearing loss refers to impaired auditory function that occurs due to genetic causes. GJB2 is the gene responsible ...
R75W mutation in the gap junction β2 (GJB2) gene causes severe fragmentation of gap junction plaques, connecting adjacent ...
Congenital hearing loss refers to impaired auditory function that occurs due to genetic causes. GJB2 is the gene responsible for approximately half of ...
17h
AZoLifeSciences on MSNBreakthrough Gene Therapy Shows Promise for Treating Hereditary Hearing LossCongenital hearing loss refers to impaired auditory function that occurs due to genetic causes. GJB2 is the gene responsible ...
ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Jumpcode Genomics ('Jumpcode'), a life science tools company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results